FDA Inspection
Wyeth Pharmaceutical Division of Wyeth Holdings LLCWyeth Pharmaceutical Division of Wyeth Holdings LLC – FDA Inspection, Mar 17, 2017
Record Details
This FDA Inspection record concerns Wyeth Pharmaceutical Division of Wyeth Holdings LLC, with an inspection on March 17, 2017, issued by the New York District Office, covering human drugs.
- Inspection Date
- March 17, 2017
- Product Type
- Human Drugs
- Office
- New York District Office
- People
- Diane L. Raccasi (Issuing Officer)
- Maria J. Lopez- Barragan (Issuing Officer)
- Wayne E. Seifert (Senior Regulatory Specialist)
View Company Profile
ID · 9eb30db2-e535-4f13-8fc9-2e0d1933aa6a
Inspection Facts
- Inspection number
- 1011662
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Wyeth Pharmaceutical Division of Wyeth Holdings LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| December 17, 2025 | VAI | New York District Office | Drug Quality Assurance |
| August 28, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 13, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 24, 2012 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| July 18, 2012 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
Other documents for Wyeth Pharmaceutical Division of Wyeth Holdings LLC
- FDA Inspection 1295786 - 2025-12-17
- FDA Inspection 1237528 - 2024-08-28
- FDA Inspection 1168201 - 2022-04-13
- FDA Inspection 804865 - 2012-10-24
- FDA Inspection 791692 - 2012-07-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.